請點擊此處查看繁體中文版本

请点击此处查看简体中文版本

日本語版を見るにはここをクリックしてください

한국어 버전은 여기를 클릭하십시오

 

Click here to listen to the webcast.

 

Further to our recent client update on the Cayman Islands Mutual Funds (Amendment) Bill, 20201, the proposed amendments to the Mutual Funds Law (2020 Revision) (the "Law") requiring the registration of mutual funds that were previously exempted from registration under section 4(4) of the Law2 ("Section 4(4) Funds") have now passed into law.

 

Commencement and Timing

 

The amendments came into force on 7 February 2020 (the "Commencement Date").  Existing Section 4(4) Funds will need to comply with the registration requirements by 7 August 2020.  New Section 4(4) Funds that start carrying on business after the Commencement Date will need to comply with the registration requirements with immediate effect.

 

Your regular Maples Group contact will be in touch on next steps for funds affected by these amendments.

 

Operator Requirements

 

Section 4(4) Funds will need to comply with the Cayman Islands Monetary Authority ("CIMA") 'four-eyes' principle that requires them to have at least two natural persons in management roles.  Existing Section 4(4) Funds will need to review the current make-up of their boards or other governing bodies to determine if they satisfy this principle.

 

In addition, each director or manager of a Section 4(4) Fund structured as a Cayman Islands exempted company or limited liability company will need to register under the Directors Registration and Licensing Law, 2014 ("DRLL Registration") if not already registered.  DRLL Registration is a simple process involving an online filing and payment of a fee through CIMA's director gateway portal.

 

Section 4(4) Filing Requirements

 

As part of the registration process, Section 4(4) Funds will need to prepare and file a registration form, which is expected to be similar to the form currently filed for mutual funds registered under section 4(3) of the Law.  However, a Section 4(4) Fund will not be required to file an offering document (or any amendments) with CIMA.  A prescribed fee will also be payable on registration and in January of each year thereafter.

 

Print Ready Version.

If you would like further information, please contact your regular Maples Group contact or any of the contacts listed below.


2. On the basis of having 15 or fewer investors, a majority of whom can appoint and remove the operator of the fund.

CONTACTS

bioImage

Jon Fowler

Partner

+1 345 814 5526

bioImage

Michael Richardson

Partner

+1 345 814 5532

bioImage

Jonathan Green

Global Managing Partner

+1 345 814 5466

bioImage

Gwyneth Rees

Partner

+1 345 814 5220

bioImage

Christina Bodden

Partner

+1 345 814 5180

bioImage

Christie Walton

Partner

+1 345 814 5349

bioImage

Andrew Keast

Partner

+1 345 814 5371

bioImage

Philip Ireland

Partner

+971 4 360 4073

bioImage

Anthony Webster

Partner

+852 2971 3001

bioImage

Ann Ng

Partner

+852 3690 7475

bioImage

Terence Ho

Partner

+852 2971 3097

bioImage

Sharon Yap

Partner

+852 2971 3079

bioImage

Harjit Kaur

Partner

+44 20 7466 1655

bioImage

Heidi de Vries

Managing Partner

+44 20 7466 1651

bioImage

Tom Katsaros

Partner

+65 6922 8403

*
*
*
*

Please note that your email may be received and read by other Maples and Calder lawyers in addition to your intended recipient.

*
*
*

Please note that your email may be received and read by other Maples Group employees in addition to your intended recipient.

Connect

Want to get in touch ?

Contact Us